Champions Oncology, Inc.
CSBRNASDAQHealthcareBiotechnology

About Champions Oncology

Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Company Information

CEORobert Brainin
Founded1985
IPO DateMarch 25, 1986
Employees213
CountryUnited States
Fiscal YearMay - April

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone201 808 8400
Address
One University Plaza, Suite 307 Hackensack, New Jersey 07601 United States

Corporate Identifiers

CIK0000771856
CUSIP15870P307
ISINUS15870P3073
EIN52-1401755
SIC2836

Leadership Team & Key Executives

Robert Brainin
Chief Executive Officer and Director
Dr. Ronnie Morris M.D.
Executive Chair
David Barry Miller M.B.A.
Chief Financial Officer
Dr. Maria Mancini Ph.D.
Chief Operating Officer
Dr. Marianna Zipeto Ph.D.
Executive Vice President of Commercial, Research Services and Partnering